Evidence map›Paper›PMID 34919053›Full record

ArticleeLife2021

5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function.

Elitsa Stoyanova, Michael Riad, Anjana Rao, Nathaniel Heintz

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Cell identity and 5-hydroxymethylcytosine.Epigenetics & chromatin · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Histone bivalency in CNS development.Genes & development · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Epigenetics and the timing of neuronal differentiation.Current opinion in neurobiology · 2024
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Elitsa StoyanovaLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States.ORCID 0000-0001-6400-6119
Michael RiadLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States.
Anjana RaoSanford Consortium for Regenerative Medicine, La Jolla, United States.ORCID 0000-0002-1870-1775
Nathaniel HeintzLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States.ORCID 0000-0002-8874-8704
Howard Hughes Medical Institute · USLa Jolla Institute for Immunology · US

Funding

The TET-DNMT-ASXL1-OGT axis: relevance to clonal hematopoiesis, heterochromatin integrity and cancerR35CA210043 · NCI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Anjana Rao · 2016 to 2026
$10.6M
Howard Hughes Medical InstituteNCI NIH HHS R35 CA210043
6 · The paper itself

Abstract

Although high levels of 5-hydroxymethylcytosine (5hmC) accumulate in mammalian neurons, our knowledge of its roles in terminal differentiation or as an intermediate in active DNA demethylation is incomplete. We report high-resolution mapping of DNA methylation and hydroxymethylation, chromatin accessibility, and histone marks in developing postmitotic Purkinje cells (PCs) in

Indexed as

Cell Differentiation5-MethylcytosineAnimalsDemethylationMiceNeurons5-hydroxymethylcytosine5-Methylcytosine5-hydroxymethylcytosineDNA demethylationgeneticsgenomicsmouseneuroscienceTET proteins

Identifiers

PMID34919053
PMCPMC8683082
OpenAlexW4200215171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.